Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Resumen

Substance use disorders (SUDs) are heterogeneous and complex, making the development of translationally predictive rodent and nonhuman primate models to uncover their neurobehavioral underpinnings difficult. Neuroscience-focused outcomes have become highly prevalent, and with this, the notion that SUDs are disorders of the brain embraced as a dominant theoretical orientation to understand SUD etiology and treatment. These efforts, however, have led to few efficacious pharmacotherapies, and in some cases (as with cocaine or methamphetamine), no pharmacotherapies have translated from preclinical models for clinical use. In this theoretical commentary, we first describe the development of animal models of substance use behaviors from a historical perspective. We then define and discuss three logical fallacies including 1) circular explanation, 2) affirming the consequent, and 3) reification that can apply to developed models. We then provide three case examples in which conceptual or logical issues exist in common methods (i.e., behavioral economic demand, escalation, and reinstatement). Alternative strategies to refocus behavioral models are suggested for the field to better bridge the translational divide between animal models, the clinical condition of SUDs, and current and future regulatory pathways for intervention development.

Idioma originalEnglish
Páginas (desde-hasta)384-403
Número de páginas20
PublicaciónJournal of the Experimental Analysis of Behavior
Volumen117
N.º3
DOI
EstadoPublished - may 2022

Nota bibliográfica

Publisher Copyright:
© 2022 Society for the Experimental Analysis of Behavior.

Financiación

We would like to thank Dr. Joshua S. Beckmann (University of Kentucky), Drs. David H. Epstein and Yavin Shaham (National Institute on Drug Abuse Intramural Program), and Dr. Derek D. Reed (University of Kansas) for insightful comments on an earlier draft of this manuscript. Funding was provided by the National Institutes of Health grants DA054098 (to JCS), DA053820 (to MLB), DA046526, DA044479, DA045881 (to CDG), and DA049130 (to CDG and WWS). Authors declare no conflicts of interest. We would like to thank Dr. Joshua S. Beckmann (University of Kentucky), Drs. David H. Epstein and Yavin Shaham (National Institute on Drug Abuse Intramural Program), and Dr. Derek D. Reed (University of Kansas) for insightful comments on an earlier draft of this manuscript. Funding was provided by the National Institutes of Health grants DA054098 (to JCS), DA053820 (to MLB), DA046526, DA044479, DA045881 (to CDG), and DA049130 (to CDG and WWS). Authors declare no conflicts of interest.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)DA044479, DA049130, DA053820, DA046526, DA054098
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseR03DA045881
University of Kentucky
University of Kansas and University of Kansas Cancer Center

    ASJC Scopus subject areas

    • Experimental and Cognitive Psychology
    • Behavioral Neuroscience

    Huella

    Profundice en los temas de investigación de 'Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience'. En conjunto forman una huella única.

    Citar esto